News

iZafe Group AB (publ) ("iZafe" or the "Company") has today entered into a share purchase agreement with the owners of Pilloxa AB ("Pilloxa") regarding the acquisition of all outstanding shares of Pilloxa in accordance with...

iZafe Group (publ.) hereby announces that it has signed a cooperation agreement with ApoEx AB, which is a supplier of pharmacy services, systems and dosage bags to privately and publicly run healthcare providers. “iZafe and the medicine robot Dosell...

iZafe Group AB (publ.) - presents today, November 7, its report for the third quarter of 2022. Summary of financial performance Significant events during the quarter Significant events after the end of the quarter COMMENTS FROM THE CEO A lot has happened...

iZafe Group (publ.) hereby announces that it has signed a cooperation agreement with Medcam AB, which sells medical technology products to healthcare in the Nordics and Europe. In the first place, the focus will be on the Dutch market, but the company...

iZafe Group AB (publ.) (”iZafe” or the ”Company”) today announces the outcome of the exercise of warrants of series TO10B, which were issued during the fourth quarter of 2021. In total, 12,072,688 warrants of series TO10B were...

iZafe Group AB (publ.) announces today that it is starting a pilot project with Aleris. The aim of the project is to produce decision-making material for a potential introduction of the pharmaceutical robot Dosell in Aleris for the patient group advanced...

iZafe Group (publ.) hereby announces that the partner Remedio has sold its concept to 12 pharmacies which in a short time have 2,000 active customers who receive their medicines in sachets. "Getting the medicine in sachets is completely new to the...

Today, October 7, 2022, is the last day of trading with the warrants of series TO10B in iZafe Group AB (“iZafe” or “the Company”). The subscription period for the warrants of series TO10B runs up until October 11, 2022. Each warrant...

iZafe Group (publ.) hereby announces that two municipalities in Sweden are choosing to implement Dosell now in October. "We see an increased demand from municipalities that wish to implement Dosell, the period for implementation is short before the...

Members of the Board of Directors, management team and the incoming Chairman of the Board of iZafe Group AB ("iZafe" or the "Company") exercise all held warrants of series TO10B. The number of warrants of series TO10B that the Board...

iZafe Group (publ.) hereby announces that the partner Hepro AS is now starting the implementation of 25 Dosell units in a municipality in the western region of Norway. The municipality, which has approximately 3,300 residents aged 65 and over, initially...

iZafe Group (publ.) hereby announces that the partner Careium AS is now starting the implementation of 20 Dosells in a municipality in eastern Norway. The municipality, which has approx. 5,171 residents aged 65 and over, will initially start with 20 Dosells...

iZafe Group AB ("iZafe" or the "Company") issued, in connection with a rights issue in the fourth quarter of 2021, warrants of series TO10B. Each warrant gives the right to subscribe for one (1) new share of series B in the Company...

iZafe Group (publ) hereby announces that the nomination committee proposes that Björn Rosengren be elected as the new chairman of the board at an extra general meeting. This means that Björn Rosengren is proposed to take over as new chairman...

iZafe Group (publ.) hereby announces that the partner Careium AB is today starting the implementation of Dosell in a municipality. "As we communicated on June 8 and that in connection with delivery challenges and approaching holiday times, the majority...

iZafe Group (publ.) hereby announces that iZafe has signed a cooperation agreement with the welfare platform Avanto Care to be able to offer customers more proactive care. "In order for future care to be able to work smart with all the advantages...

iZafe Group (publ.) has today notified the board of its decision to resign as chairman of the board for iZafe Group. "In connection with the upcoming acquisition and the fact that I myself have many new assignments, I have finally made the choice...

iZafe Group AB (publ.) - presents today, August 26, its report for the second quarter. Summary of financial performance Significant events in the quarter Significant events after the end of the quarter COMMENTS FROM THE CEO Our vision is to ensure health...

iZafe Group AB (publ) - announces that in connection with the interim report for the second quarter of 2022, which will be published at 08:30 CET on August 26, 2022, shareholders, media, and other stakeholders will be given the opportunity to ask questions...

iZafe Group (publ.) hereby invites you to a live interview with Pilloxa's CEO Helena Rönnqvist and iZafe Group's CEO Anders Segerström on Wednesday, August 24 at 2 p.m. due to the fact that iZafe has signed a letter of intent with...

iZafe Group AB (publ) ("iZafe" or the "Company") has signed a Letter of Intent with Pilloxa AB ("Pilloxa") regarding the acquisition of 100 percent of the shares in Pilloxa (the "Acquisition"). Pilloxa has developed...